Other Species / Isoforms
  RAIG1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K285-ub
PVEDAFCkPQLVkks
0 5
RAIG1 (human) PVEDAFCkPQLVkks K285-ub
RAIG1 (mouse) PVEDAFCkPQLMKQS K287-ub
RAIG1 (rat) PVEDAFCKPQLMKQS K118
K290-ub
FCkPQLVkksyGVEN
0 3
RAIG1 (human) FCkPQLVkksyGVEN K290-ub
RAIG1 (mouse) FCkPQLMKQSYGVEN K292
RAIG1 (rat) FCKPQLMKQSYGVEN K123
K291-ub
CkPQLVkksyGVENR
0 3
RAIG1 (human) CkPQLVkksyGVENR K291-ub
RAIG1 (mouse) CkPQLMKQSYGVENR Q293
RAIG1 (rat) CKPQLMKQSYGVENR Q124
S292-p
kPQLVkksyGVENRA
0 1
RAIG1 (human) kPQLVkksyGVENRA S292-p
RAIG1 (mouse) kPQLMKQSYGVENRA S294
RAIG1 (rat) KPQLMKQSYGVENRA S125
Y293-p
PQLVkksyGVENRAy
0 36
RAIG1 (human) PQLVkksyGVENRAy Y293-p
RAIG1 (mouse) PQLMKQSYGVENRAY Y295
RAIG1 (rat) PQLMKQSYGVENRAY Y126
Y300-p
yGVENRAysQEEItQ
0 48
RAIG1 (human) yGVENRAysQEEItQ Y300-p
RAIG1 (mouse) YGVENRAYsQEEITQ Y302
RAIG1 (rat) YGVENRAYsQEEITQ Y133
S301-p
GVENRAysQEEItQG
Upstream
0 26
Treatment
  • ephrin_B1
  • UV
RAIG1 (human) GVENRAysQEEItQG S301-p
RAIG1 (mouse) GVENRAYsQEEITQG S303-p
RAIG1 (rat) GVENRAYsQEEITQG S134-p
T306-p
AysQEEItQGFEEtG
0 5
RAIG1 (human) AysQEEItQGFEEtG T306-p
RAIG1 (mouse) AYsQEEITQGLEMGD T308
RAIG1 (rat) AYsQEEITQGLEEMG T139
T312-p
ItQGFEEtGDtLyAP
0 10
RAIG1 (human) ItQGFEEtGDtLyAP T312-p
RAIG1 (mouse) EITQGLEMGDTLyAP M313
RAIG1 (rat) ITQGLEEMGDTLYAP M145
T315-p
GFEEtGDtLyAPyst
0 13
RAIG1 (human) GFEEtGDtLyAPyst T315-p
RAIG1 (mouse) QGLEMGDTLyAPySt T316
RAIG1 (rat) GLEEMGDTLYAPYST T148
Y317-p
EEtGDtLyAPystHF
Upstream
Downstream
1 302
Effects on Biological Processes:
  • cell growth, induced
Putative in vivo kinases:
  • EGFR (human)
Treatment
  • EGF
RAIG1 (human) EEtGDtLyAPystHF Y317-p
RAIG1 (mouse) LEMGDTLyAPyStHF Y318-p
RAIG1 (rat) EEMGDTLYAPYSTHF Y150
Y320-p
GDtLyAPystHFQLQ
Upstream
Downstream
1 185
Effects on Biological Processes:
  • cell growth, induced
Putative in vivo kinases:
  • EGFR (human)
Treatment
  • EGF
  • ephrin_B1
  • ephrin_B2
RAIG1 (human) GDtLyAPystHFQLQ Y320-p
RAIG1 (mouse) GDTLyAPyStHFQLQ Y321-p
RAIG1 (rat) GDTLYAPYSTHFQMQ Y153
S321-p
DtLyAPystHFQLQN
0 20
RAIG1 (human) DtLyAPystHFQLQN S321-p
RAIG1 (mouse) DTLyAPyStHFQLQN S322
RAIG1 (rat) DTLYAPYSTHFQMQN S154
T322-p
tLyAPystHFQLQNQ
0 24
RAIG1 (human) tLyAPystHFQLQNQ T322-p
RAIG1 (mouse) TLyAPyStHFQLQNH T323-p
RAIG1 (rat) TLYAPYSTHFQMQNR T155
K333-ub
LQNQPPQkEFsIPRA
0 3
RAIG1 (human) LQNQPPQkEFsIPRA K333-ub
RAIG1 (mouse) FQLQNHQKDFsIPRA K332
RAIG1 (rat) FQMQNRQKDFsIPRA K164
S336-p
QPPQkEFsIPRAHAW
Upstream
0 18
Treatment
  • ischemia
RAIG1 (human) QPPQkEFsIPRAHAW S336-p
RAIG1 (mouse) QNHQKDFsIPRAQAP S335-p
RAIG1 (rat) QNRQKDFsIPRAHTP S167-p
S345-p
PRAHAWPsPykDyEV
Upstream
0 222
Treatment
  • nocodazole
RAIG1 (human) PRAHAWPsPykDyEV S345-p
RAIG1 (mouse) PRAQAPAsPyNDyEG S344-p
RAIG1 (rat) PRAHTPAsPYNDYEG S176-p
Y347-p
AHAWPsPykDyEVkK
Upstream
Downstream
1 846
Effects on Biological Processes:
  • cell growth, induced
Putative in vivo kinases:
  • EGFR (human)
Treatment
  • EGF
  • erlotinib
RAIG1 (human) AHAWPsPykDyEVkK Y347-p
RAIG1 (mouse) AQAPAsPyNDyEGRK Y346-p
RAIG1 (rat) AHTPAsPYNDYEGRK Y178
K348-ub
HAWPsPykDyEVkKE
0 9
RAIG1 (human) HAWPsPykDyEVkKE K348-ub
RAIG1 (mouse) QAPAsPyNDyEGRKG N347
RAIG1 (rat) HTPAsPYNDYEGRKG N179
Y350-p
WPsPykDyEVkKEGs
Upstream
Downstream
1 821
Effects on Biological Processes:
  • cell growth, induced
Putative in vivo kinases:
  • EGFR (human)
Treatment
  • EGF
  • ephrin_B1
RAIG1 (human) WPsPykDyEVkKEGs Y350-p
RAIG1 (mouse) PAsPyNDyEGRKGDs Y349-p
RAIG1 (rat) PAsPYNDYEGRKGDS Y181
K353-ub
PykDyEVkKEGs___
0 1
RAIG1 (human) PykDyEVkKEGs___ K353-ub
RAIG1 (mouse) PyNDyEGRKGDs___ R352
RAIG1 (rat) PYNDYEGRKGDS___ R184
S357-p
yEVkKEGs_______
0 53
RAIG1 (human) yEVkKEGs_______ S357-p
RAIG1 (mouse) yEGRKGDs_______ S356-p
RAIG1 (rat) YEGRKGDS_______ S188